Drug intelligence / Profile preview

fluticasone propionate + azelastine hydrochloride

Development stage
Unknown
Lead developer
Viatris
Modality
Small Molecules
Administration
Intranasal
01

Overview

Flutix Duo is a fixed-dose combination nasal spray developed by Ernst Pharmacia, containing the corticosteroid fluticasone propionate and the antihistamine azelastine hydrochloride. It is primarily indicated for the symptomatic relief of seasonal and perennial allergic rhinitis in patients where monotherapy with either an antihistamine or a corticosteroid is considered insufficient. Fluticasone propionate works by binding to glucocorticoid receptors to inhibit the production of inflammatory mediators, while azelastine hydrochloride provides rapid relief by competitively antagonizing H1 receptors. This dual-action approach effectively addresses both the inflammatory and histamine-mediated components of allergic rhinitis, improving symptoms such as nasal congestion, rhinorrhea, and sneezing.

Brand names
Flutix DuoFlutix-Duo
02

Targets

GR (Glucocorticoid receptor)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on fluticasone propionate + azelastine hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluticasone propionate + azelastine hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call